52 patents
Utility
Gamma-hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
30 Nov 23
Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof).
Sanjib BERA, Dibyendu DANA, Sven GUENTHER, Adam SMITH, Travis MICKLE
Filed: 19 Apr 23
Utility
Gamma-hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
30 Nov 23
Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof).
Sanjib BERA, Sven GUENTHER, Adam SMITH, Travis MICKLE
Filed: 19 Apr 23
Utility
Gamma-hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
30 Nov 23
Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof).
Sanjib BERA, Dibyendu DANA, Sven GUENTHER, Adam SMITH, Travis MICKLE
Filed: 19 Apr 23
Utility
Ketamine Compounds and Processes for Making and Using Them
9 Nov 23
Disclosed are compounds comprising ketamine (2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone) chemically conjugated to one or more oxoacids, amino acids, polyethylene glycols (PEG or PEO), peptides, phosphates, and/or vitamin compounds, and salts of such compounds.
Guochen CHI, Sven GUENTHER, Travis MICKLE, Adam SMITH
Filed: 20 Jul 23
Utility
Gamma-hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
26 Oct 23
Disclosed are compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof).
Sanjib BERA, Dibyendu DANA, Sven GUENTHER, Adam SMITH, Travis MICKLE
Filed: 19 Apr 23
Utility
Ketamine compounds and processes for making and using them
12 Sep 23
Disclosed are compounds comprising ketamine (2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone) chemically conjugated to one or more oxoacids, amino acids, polyethylene glycols (PEG or PEO), peptides, phosphates, and/or vitamin compounds, and salts of such compounds.
Guochen Chi, Sven Guenther, Travis Mickle, Adam Smith
Filed: 18 Apr 22
Utility
Compositions comprising methylphenidate-prodrugs, processes of making and using the same
22 Nov 22
The present technology is directed to compositions comprising d-threo-methylphenidate conjugates and/or unconjugated methylphenidate.
Travis Mickle, Sven Guenther, Guochen Chi
Filed: 8 Dec 20
Utility
Ketamine Compounds and Processes for Making and Using Them
3 Nov 22
Disclosed are compounds comprising ketamine (2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone) chemically conjugated to one or more oxoacids, amino acids, polyethylene glycols (PEG or PEO), peptides, phosphates, and/or vitamin compounds, and salts of such compounds.
Guochen CHI, Sven GUENTHER, Travis MICKLE, Adam SMITH
Filed: 18 Apr 22
Utility
Levorphanol Prodrugs and Processes for Making and Using Them
31 Mar 22
The presently described technology provides compositions of one or more of oxoacids, amino acids, polyethylene glycols, and/or vitamin compounds chemically conjugated to levorphanol ((−)-17-methylmorphinan-3-ol) to form novel prodrugs and compositions of levorphanol.
Travis Mickle, Sven Guenther, Sanjib Bera
Filed: 14 Dec 21
Utility
Dextrorphan Prodrugs and Processes for Making and Using Them
24 Mar 22
The presently described technology provides compositions of one or more of oxoacids, polyethylene glycols, and/or vitamin compounds chemically conjugated to dextrorphan, (+)-17-methylmorphinan-3-ol), to form novel prodrugs and compositions of dextrorphan.
Travis Mickle, Sven Guenther, Sanjib Bera
Filed: 29 Nov 21
Utility
D-amphetamine Compounds, Compositions, and Processes for Making and Using the Same
3 Mar 22
Sven Guenther, Guochen Chi, Travis Mickle
Filed: 13 Oct 21
Utility
Levorphanol prodrugs and processes for making and using them
1 Feb 22
The presently described technology provides compositions of one or more of oxoacids, amino acids, polyethylene glycols, and/or vitamin compounds chemically conjugated to levorphanol ((−)-17-methylmorphinan-3-ol) to form novel prodrugs and compositions of levorphanol.
Travis Mickle, Sven Guenther, Sanjib Bera
Filed: 12 Apr 18
Utility
Dextrorphan prodrugs and processes for making and using them
4 Jan 22
The presently described technology provides compositions of one or more of oxoacids, polyethylene glycols, and/or vitamin compounds chemically conjugated to dextrorphan, (+)-17-methylmorphinan-3-ol), to form novel prodrugs and compositions of dextrorphan.
Travis Mickle, Sven Guenther, Sanjib Bera
Filed: 12 Apr 18
Utility
D-amphetamine compounds, compositions, and processes for making and using the same
16 Nov 21
Sven Guenther, Guochen Chi, Travis Mickle
Filed: 29 Oct 19
Utility
D-amphetamine compounds, compositions, and processes for making and using the same
5 Oct 21
Disclosed are d-amphetamine compounds and compositions comprising at least one organic acid covalently bound to d-amphetamine, a salt thereof, a derivative thereof, or a combination thereof.
Sven Guenther, Guochen Chi, Travis Mickle
Filed: 29 Oct 19
Utility
Compositions Comprising Methylphenidate-prodrugs, Processes of Making and Using the Same
19 Aug 21
The present technology is directed to d-threo-methylphenidate conjugates and a composition comprising d-threomethylphenidate conjugated to nicotinoyl-L-serine, or salt thereof.
Travis Mickle, Sven Guenther, Guochen Chi
Filed: 26 Apr 21
Utility
Compositions comprising methylphenidate-prodrugs, processes of making and using the same
1 Jun 21
Travis Mickle, Sven Guenther, Guochen Chi
Filed: 20 Sep 19
Utility
Compositions comprising methylphenidate-prodrugs, processes of making and using the same
1 Jun 21
Travis Mickle, Sven Guenther, Guochen Chi
Filed: 20 Sep 19
Utility
Compositions Comprising Methylphenidate-prodrugs, Processes of Making and Using the Same
6 May 21
The present technology is directed to compositions comprising d-threo-methylphenidate conjugates and/or unconjugated methylphenidate.
Travis Mickle, Sven Guenther, Guochen Chi
Filed: 8 Dec 20
Utility
Compositions comprising methylphenidate-prodrugs, processes of making and using the same
23 Mar 21
Travis Mickle, Sven Guenther, Guochen Chi
Filed: 30 Sep 19